Adcetris

List of products in the National Drug Code with proprietary name adcetris. Brentuximab is used to treat certain types of cancers (Hodgkin's lymphoma, systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides). It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
51144-050Adcetris Brentuximab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.Human Prescription Drug